Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$495M |
| 2 |
ExxonMobil
XOM
|
+$290M |
| 3 |
FedEx
FDX
|
+$273M |
| 4 |
Netflix
NFLX
|
+$262M |
| 5 |
RTX Corp
RTX
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
EA
Electronic Arts
EA
|
+$280M |
| 3 |
Mastercard
MA
|
+$252M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.15% |
| 2 | Technology | 16.1% |
| 3 | Financials | 11.82% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYRS
2551
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.06M | ﹤0.01% |
7,220
+4,520
| +167% | +$850K |
|
2552
Nomad Foods
NOMD
$1.68B
| $1.06M | ﹤0.01% |
72,918
-358,882
| -83% | -$5.24M |
|
|
CYRN
2553
DELISTED
CYREN Ltd.
CYRN
| $1.06M | ﹤0.01% |
29,202
-410
| -1% | -$14.7K |
|
2554
Travelers Companies
TRV
$77.2B
| $1.05M | ﹤0.01% |
8,600
-91,100
| -91% | -$11.4M |
|
|
BLPH
2555
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $1.05M | ﹤0.01% |
49,333
+8,113
| +20% | +$151K |
|
|
HOME
2556
DELISTED
At Home Group Inc.
HOME
| $1.05M | ﹤0.01% |
45,900
-3,300
| -7% | -$75.9K |
|
2557
NetSol Technologies
NTWK
$49.3M
| $1.05M | ﹤0.01% |
299,000
-6,300
| -2% | -$26.6K |
|
|
TLGT
2558
DELISTED
Teligent, Inc
TLGT
| $1.04M | ﹤0.01% |
15,527
+11,297
| +267% | +$827K |
|
2559
Littelfuse
LFUS
$11.4B
| $1.04M | ﹤0.01% |
5,292
-28,800
| -84% | -$5.23M |
|
2560
ImmunityBio
IBRX
$8.11B
| $1.04M | ﹤0.01% |
189,100
+99,700
| +112% | +$614K |
|
2561
Dana Inc
DAN
$3.26B
| $1.03M | ﹤0.01% |
+37,035
| New | +$899K |
|
|
CEA
2562
DELISTED
China Eastern Airlines
CEA
| $1.03M | ﹤0.01% |
42,200
-10,400
| -20% | -$287K |
|
|
TI
2563
DELISTED
Telecom Italia
TI
| $1.03M | ﹤0.01% |
+109,506
| New | +$1.06M |
|
|
SUP
2564
DELISTED
Superior Industries International
SUP
| $1.03M | ﹤0.01% |
61,700
-110,300
| -64% | -$1.88M |
|
|
ORC
2565
Orchid Island Capital
ORC
$1.32B
| $1.02M | ﹤0.01% |
20,080
-41,120
| -67% | -$2.02M |
|
2566
Compugen
CGEN
$228M
| $1.02M | ﹤0.01% |
268,700
-106,400
| -28% | -$369K |
|
2567
First Hawaiian
FHB
$3.36B
| $1.02M | ﹤0.01% |
33,700
-8,100
| -19% | -$234K |
|
|
RDS.B
2568
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.02M | ﹤0.01% |
+16,327
| New | +$937K |
|
|
CMRX
2569
DELISTED
Chimerix, Inc.
CMRX
| $1.02M | ﹤0.01% |
193,960
+151,000
| +351% | +$743K |
|
2570
Compass Diversified
CODI
$924M
| $1M | ﹤0.01% |
+56,543
| New | +$976K |
|
|
IOTS
2571
DELISTED
Adesto Technologies Corp
IOTS
| $1M | ﹤0.01% |
127,800
+117,300
| +1,117% | +$710K |
|
2572
Kforce
KFRC
$1.03B
| $997K | ﹤0.01% |
+49,349
| New | +$916K |
|
2573
Arbutus Biopharma
ABUS
$908M
| $996K | ﹤0.01% |
160,610
-49,629
| -24% | -$212K |
|
2574
First Horizon
FHN
$12.3B
| $994K | ﹤0.01% |
51,881
-1,475,500
| -97% | -$25.9M |
|
|
PCSB
2575
DELISTED
PCSB Financial Corporation
PCSB
| $994K | ﹤0.01% |
+52,700
| New | +$918K |
|
Similar funds
Jim Simons's Q3 2017 Portfolio in Review
As of Q3 2017, Jim Simons held 3,587 positions worth $85B, up 8.4% from $78.4B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
Jim Simons deployed $2.91B of net new capital in Q3 2017, opening 418 new positions and adding to 1,684 existing holdings. Its largest new stake was ExxonMobil: 3,652,454 shares worth $299M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Electronic Arts, an estimated $280M trimmed.
- Jim Simons's largest Q3 2017 buy was ExxonMobil: 3,652,454 shares worth $299M.
- Jim Simons added most to Medtronic in Q3 2017, an estimated $495M increase.
- Jim Simons's biggest Q3 2017 reduction was Electronic Arts, cutting an estimated $280M.
- Jim Simons fully exited Amazon in Q3 2017, selling an estimated $290M.
- Jim Simons's ten largest holdings make up 8.5% of its $85B portfolio in Q3 2017.
- Jim Simons opened 418 new positions and closed 418 in Q3 2017.
- Jim Simons's portfolio value rose 8.4% quarter-over-quarter to $85B.
Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.